InvestorsHub Logo

mrwrn2010

03/23/24 2:32 PM

#398295 RE: bubba412 #398294

I hope I’m right too, also simply posing the question. Nothing is a sure thing but it just seems like it would make more sense to be concerned if the company had a track record of failing to get generics approved. Thus far, that has not been the case.

I am optimistic that the growing revenues, the facility expansion, the multiple ANDAs under review, and the further ANDAs in trials and formulation will lead to a higher PPS.